← Leaderboards
Kenneth B Ain
University Of Kentucky
$901,834
Attributed
$901,834
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $226.5K · FY2008–11$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$901,834 · 4
By mechanism
R01$629,495 · 1
K24$267,325 · 1
M01$5,014 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Bernard Mark Evers$41,615,341
- Craig R Rush$27,535,139
- Gregory A Jicha$17,898,620
- Edward D Hall$10,672,048
- Frederick Schmitt$9,256,885
Others in their field
Top investigators on “Iodine”
- Claude P Lechene · Brigham And Women'S Hospital$12,575,028
- Michael Rod Zalutsky · Duke University$12,539,817
- Philip Reed Larsen · Brigham And Women'S Hospital$7,972,045
- Benjamin M Yeh · University Of California, San Francisco$6,888,949
- Eric A Hoffman · University Of Iowa$6,616,767
- Peter M. Milgrom · University Of Washington$6,292,250
Research focus
IodineHuman Therapy EvaluationHuman SubjectButyratesClinical ResearchDna MethylationCell LineThyroid NeoplasmAzacitidineNeoplasm /Cancer Radionuclide TherapyNeoplasm /Cancer ChemotherapySodium IonMembrane Transport ProteinsPhenylacetatesMetastasisNeoplasm /Cancer InvasivenessCadherinsGenetic Promoter ElementHydroxyureaAthymic MouseCombination ChemotherapyCombination Cancer TherapyGene Induction /RepressionThyroxine
Grant awards (13)
Transcriptional Repression of Sodium-Iodide Symporter in Thyroid Carcinoma$226,495
R01 · FY2011 · CA · contact PI
Transcriptional Repression of Sodium-Iodide Symporter in Thyroid Carcinoma$151,000
R01 · FY2010 · CA · contact PI
Transcriptional Repression of Sodium-Iodide Symporter in Thyroid Carcinoma$126,000
R01 · FY2009 · CA · contact PI
Transcriptional Repression of Sodium-Iodide Symporter in Thyroid Carcinoma$126,000
R01 · FY2008 · CA · contact PI
DEMETHYLATION THERAPY OF THYROID CARCINOMA$55,052
K24 · FY2004 · CA
Phase II Trial of Thalidimide$5,014
M01 · FY2004 · RR
DEMETHYLATION THERAPY OF THYROID CARCINOMA$54,235
K24 · FY2003 · CA
DEMETHYLATION THERAPY OF THYROID CARCINOMA$53,442
K24 · FY2002 · CA
RESTORATION OF RADIOIODINE UPTAKE IN THYROID CARCINOMA$0
M01 · FY2002 · RR
DEMETHYLATION THERAPY OF THYROID CARCINOMA$52,672
K24 · FY2001 · CA
RESTORATION OF RADIOIODINE UPTAKE IN THYROID CARCINOMA$0
M01 · FY2001 · RR
DEMETHYLATION THERAPY OF THYROID CARCINOMA$51,924
K24 · FY2000 · CA
RESTORATION OF RADIOIODINE UPTAKE IN THYROID CARCINOMA$0
M01 · FY2000 · RR